Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00258_DB00884_nanopub.RAyQHCNfjfzBnaXB8mVmqA4mhrUoSW3C-6BQIG1b16v6g#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00258_DB00884 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00258_DB00884 label "DDI between Calcium Acetate and Risedronate - Calcium Salts may decrease the serum concentration of Bisphosphonate Derivatives such as risedronate. Avoid administration of oral calcium supplements within or 30 minutes after risedronate. [drugbank_resource:DB00258_DB00884]" assertion.
- drugbank_resource:DB00258_DB00884 identifier "drugbank_resource:DB00258_DB00884" assertion.
- drugbank_resource:DB00258_DB00884 title "DDI between Calcium Acetate and Risedronate - Calcium Salts may decrease the serum concentration of Bisphosphonate Derivatives such as risedronate. Avoid administration of oral calcium supplements within or 30 minutes after risedronate." assertion.
- drugbank:DB00258 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00258_DB00884 assertion.
- drugbank:DB00884 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00258_DB00884 assertion.